Efficacy of enoxaparin in preventing coagulation during high-flux haemodialysis, expanded haemodialysis and haemodiafiltration


Por: Santos, A, Macias, N, Vega, A, Abad, S, Linares, T, Aragoncillo, I, Cruzado, L, Pascual, C, Goicoechea, M and Lopez-Gomez, J

Publicada: 1 abr 2021 Ahead of Print: 22 jun 2020
Categoría: Nephrology

Resumen:
Background. Low-molecular-weight heparins (LMWHs) are easily dialysable with high-flow membranes; however, it is not clear whether the LMWH dose should be adjusted according to the membrane type and dialysis technique. This study aimed to evaluate the influence of the dialyser on anticoagulation of the extracorporeal dialysis circuit. Methods. Thirteen patients received the same dose of LMWH through the arterial port via three dialysis techniques: high-flux haemodialysis (HF-HD), online haemodiafiltration (HDF) and expanded haemodialysis (HDx). All dialysis was performed under similar conditions: duration, 4 h; blood flow, 400 mL/min; and dialysate flow, 500 mL/min. Antifactor Xa (aXa) activity and activated partial thromboplastin time (APTT) were measured before and after the dialysis. Clotting time of the vascular access site after haemodialysis, visual clotting score of the dialyser and any complications with the extracorporeal circuit or bleeding were registered. Results. Post-dialysis aXa activity in HF-HD (0.26 +/- 0.02 U/mL) was significantly different from that in HDF (0.21 +/- 0.02 U/mL, P = 0.024), and there was a trend in HDx (0.22 +/- 0.01 U/mL, P = 0.05). APTT post-dialysis in HF-HD (30.5 +/- 0.7 s) was significantly different from that in HDx (28.2 +/- 0.64 s, P = 0.009) and HDF (28.8 +/- 0.73 s, P = 0.009). Conclusions. AXa activity in HDF was significantly lower than that in HF-HD, possibly because of more losses of LMWH through the dialyser. Given the higher anticoagulant loss in HDF and probably in HDx than in HF-HD, the enoxaparin dose administered may be adjusted according to the dialysis technique.

Filiaciones:
:
 Hosp Univ Vinalopo, Nephrol Dept, Elche, Spain

Macias, N:
 Hosp Gen Univ Gregorio Maranon, Nephrol Dept, Madrid, Spain

Vega, A:
 Hosp Gen Univ Gregorio Maranon, Nephrol Dept, Madrid, Spain

Abad, S:
 Hosp Gen Univ Gregorio Maranon, Nephrol Dept, Madrid, Spain

Linares, T:
 Hosp Gen Univ Gregorio Maranon, Nephrol Dept, Madrid, Spain

Aragoncillo, I:
 Hosp Gen Univ Gregorio Maranon, Nephrol Dept, Madrid, Spain

:
 Hosp Univ Elche, Nephrol Dept, Elche, Spain

Pascual, C:
 Hosp Gen Univ Gregorio Maranon, Hematol Dept, Madrid, Spain

Goicoechea, M:
 Hosp Gen Univ Gregorio Maranon, Nephrol Dept, Madrid, Spain

Lopez-Gomez, J:
 Hosp Gen Univ Gregorio Maranon, Nephrol Dept, Madrid, Spain
ISSN: 20488513





CLINICAL KIDNEY JOURNAL
Editorial
Oxford University Press, GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND, Reino Unido
Tipo de documento: Article
Volumen: 14 Número: 4
Páginas: 1120-1125
WOS Id: 000642298600009
ID de PubMed: 33841857
imagen Green Published, gold

FULL TEXT

imagen Published Version CC BY CC BY-NC

MÉTRICAS